Skip directly to content

HCV World CAB Report

Forging a Path to HCV Elimination: Simpler Tests and Affordable Generics
Report of the World Community Advisory Board on HCV Generics and Diagnostics
July 18–20 2017, Bangkok, Thailand

Community Advisory Boards have long played an important role in the push to expand access to medicines and in the formulation of demands for improved responses to public health challenges. HCV Community Advisory Boards have borrowed from the precedent established by HIV activists. One key example was the 2004 HIV World Community Advisory Board formed by the International Treatment Preparedness Coalition, which was comprised of people living with HIV/AIDS and fellow comrades. CAB meetings at national, regional, and global levels have played a critical role in the exchange of information and the formulation of specific treatment access demands aimed at originator (patent holding) drug companies, scientists, and government representatives.

In this tradition, the HCV World CAB is underpinned by human rights principles. Beyond the right to health and its subsequent implications for universal access to medicines, the emphasis on human rights seeks to highlight that universal rights apply equally to key populations, many of whom suffer from active discrimination and are denied equitable access to services. CABs recognize that the most-affected communities—in particular people who inject or use drugs—play an essential role in the advocacy required to improve policies at the national and international levels. Since 2014, there have now been three different iterations of the HCV World CAB to provide space for activists in low- and middle-income countries (LMICs) to discuss some of the most pressing concerns on HCV treatment access. This iteration is the first to directly integrate diagnostic companies into the agenda.

This report first highlights developments in the HCV landscape, then provides an overview of the key takeaways from the exchange with generic and diagnostic companies.

The report is also available in French, Spanish, and Russian.